Trial intelligence / Profile preview

Phase II placebo-controlled trial of Mulberry Twig Alkaloids Tablets for weight loss in overweight or obese adults

CTR20253272Phase 2Active

Sponsor
Wuheboao Pharmaceutical
Start
Aug 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ramulus mori alkaloids in obesity, Overweight, sponsored by Wuheboao Pharmaceutical. Started Aug 2025; status: active.

02

Drugs

ramulus mori alkaloids
03

Conditions

obesityOverweight

Beyond the preview

Go deeper on CTR20253272.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20253272.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call